Literature DB >> 18690052

Time course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentin.

Fay Heblich1, Alexandra Tran Van Minh, Jan Hendrich, Katrin Watschinger, Annette C Dolphin.   

Abstract

The mechanism of action of gabapentin is still not well understood. It binds to the alpha(2)delta-1 and alpha(2)delta-2 subunits of voltage-gated calcium channels but has little acute effect on calcium currents in several systems. However, our recent results conclusively demonstrated that gabapentin inhibited calcium currents when applied chronically but not acutely, both in heterologous expression systems and in dorsal root ganglion neurons.(1) In that study we only examined a 40-hour time point of incubation with gabapentin, and here we have extended these results to include the effect of up to 6 and 20 hours incubation with gabapentin on calcium channel currents formed from Ca(V)2.1/beta(4)/alpha(2)delta-2 subunits. Gabapentin was significantly effective to inhibit the currents if included for 17-20 hours prior to recording, but it did not produce a significant inhibition if included for 3-6 hours. We previously concluded that gabapentin acts primarily at an intracellular location, requiring uptake into cells. However, this effect is mediated by alpha(2)delta subunits, being prevented by mutations in either alpha(2)delta-1 or alpha(2)delta-2 that abolish gabapentin binding.(1) Furthermore, we also showed that the trafficking of alpha(2)delta-2 and Ca(V)2 channels was disrupted by gabapentin. Here we have also extended that study, to show that the cell-surface expression of Ca(V)2.1 is not reduced by chronic gabapentin if it is co-expressed with alpha(2)delta-2 containing a point mutation (R282A) that prevents gabapentin binding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690052     DOI: 10.4161/chan.2.1.6045

Source DB:  PubMed          Journal:  Channels (Austin)        ISSN: 1933-6950            Impact factor:   2.581


  24 in total

Review 1.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2.

Authors:  Alexandra Tran-Van-Minh; Annette C Dolphin
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

3.  Functional properties and modulation of extracellular epitope-tagged Ca(V)2.1 voltage-gated calcium channels.

Authors:  Katrin Watschinger; Silja B Horak; Katrin Schulze; Gerald J Obermair; Claudia Wild; Alexandra Koschak; Martina J Sinnegger-Brauns; Robert Tampé; Jörg Striessnig
Journal:  Channels (Austin)       Date:  2008-11-15       Impact factor: 2.581

4.  Small-molecule CaVα1⋅CaVβ antagonist suppresses neuronal voltage-gated calcium-channel trafficking.

Authors:  Xingjuan Chen; Degang Liu; Donghui Zhou; Yubing Si; David Xu; Christopher W Stamatkin; Mona K Ghozayel; Matthew S Ripsch; Alexander G Obukhov; Fletcher A White; Samy O Meroueh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-24       Impact factor: 11.205

5.  Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.

Authors:  Amanda Ellis; Julie Wieseler; Jacob Favret; Kirk W Johnson; Kenner C Rice; Steven F Maier; Scott Falci; Linda R Watkins
Journal:  J Pain       Date:  2014-01-09       Impact factor: 5.820

6.  Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes.

Authors:  Masaru Yoshizumi; James C Eisenach; Ken-ichiro Hayashida
Journal:  Eur J Pharmacol       Date:  2011-12-21       Impact factor: 4.432

7.  Gabapentin inhibits catecholamine release from adrenal chromaffin cells.

Authors:  Robert D Todd; Sarah M McDavid; Rebecca L Brindley; Mark L Jewell; Kevin P M Currie
Journal:  Anesthesiology       Date:  2012-05       Impact factor: 7.892

8.  Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.

Authors:  Aubin Moutal; Wennan Li; Yue Wang; Weina Ju; Shizhen Luo; Song Cai; Liberty François-Moutal; Samantha Perez-Miller; Jackie Hu; Erik T Dustrude; Todd W Vanderah; Vijay Gokhale; May Khanna; Rajesh Khanna
Journal:  Br J Pharmacol       Date:  2017-03-17       Impact factor: 8.739

9.  The effects of intrathecal and systemic gabapentin on spinal substance P release.

Authors:  Toshifumi Takasusuki; Tony L Yaksh
Journal:  Anesth Analg       Date:  2011-03-08       Impact factor: 5.108

10.  Modulation of voltage-gated Ca2+ channels in rat retinal ganglion cells by gabapentin.

Authors:  Spring R Farrell; Allison Sargoy; Nicholas C Brecha; Steven Barnes
Journal:  Vis Neurosci       Date:  2014-01       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.